Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
6
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
6
×
wisconsin blog main
wisconsin top stories
biotech
indiana blog main
indiana top stories
fda
cancer
clinical trials
crispr
deals
eli lilly
gene editing
gene therapy
ipo
merck
moderna
novartis
vertex pharmaceuticals
What
bio
moves
6
×
roundup
week
ceo
debut
drug
gene
healthcare
life
patients
science
therapy
acquisitions
america
aren’t
becker
big
biggest
billions
biogen
black
bosley's
bosley’s
bridge
bucks
build
buy
cas
companies
company’s
continue
continues
convoluted
crime
crispr
daniel
democrats
departure
developers
Language
unset
Current search:
moves
×
" texas top stories "
×
" raleigh-durham top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More